2007 (11) TMI 21 - SC - Central Excise

Repetitive show-cause notices deemed arbitrary, abusive and invalid; proceedings quashed for being discriminatory and procedurally improper

SC upheld HC's finding that the impugned show cause notice was arbitrary and an abuse of process, being merely a repetition of earlier notices with only ... Scope of interference at show-cause notice stage - abuse of process of law - finality of judicial decision / issue estoppel - classification of goods as Ayurvedic medicines versus cosmetics - reopening concluded issuesFinality of judicial decision / issue estoppel - reopening concluded issues - classification of goods as Ayurvedic medicines versus cosmetics - Whether the show cause notice dated 29-4-2005 was impermissible because it sought to re-open issues already finally concluded by earlier judicial orders. - HELD THAT: - The Court upheld the High Court's conclusion that the classification controversy between Ayurvedic medicine and cosmetics in respect of the respondent's products had been finally adjudicated by the Bombay High Court and affirmed by this Court (including by a consent/compromise order accepting the High Court's classification and subjecting consequential relief to statutory conditions). The impugned notice was essentially a repetition of earlier notices and relied on the same tests and materials; it therefore amounted to an attempt to re-open questions already concluded by judicial decisions. In those circumstances the issuance of the fresh show cause notice constituted an abuse of process and was without jurisdiction, warranting quashing by the writ court. [Paras 31, 33, 34]Impugned show cause notice quashed as an impermissible re-opening of issues already finally decided.Scope of interference at show-cause notice stage - abuse of process of law - Whether the High Court was justified in interfering at the stage of issuance of a show cause notice. - HELD THAT: - The Court restated the normal rule that writ courts should not ordinarily interfere at the show-cause notice stage because the affected party has the opportunity to contest the notice before the adjudicating authority. However, the rule admits exceptions where a show cause notice is prima facie issued without jurisdiction or is an abuse of process of law. The present case fell within that exception: given the factual matrix and the prior judicial finality on classification, the High Court rightly concluded that prima facie the notice was an abuse and interference at the notice stage was warranted. The Court emphasised that such interference should be rare and only where abuse or lack of jurisdiction is prima facie established. [Paras 30, 32]High Court's interference at the show-cause notice stage was justified on the ground of abuse of process and lack of jurisdiction; interference at that stage remains exceptional.Final Conclusion: Appeal dismissed. The Supreme Court affirmed the High Court's quashing of the 29-4-2005 show cause notice on the basis that it impermissibly sought to re-open issues conclusively decided earlier; the Court reiterated that interference at show-cause stage is generally inappropriate but is justified where a notice is prima facie an abuse of process or issued without jurisdiction. Issues Involved:1. Jurisdiction and validity of the show cause notice issued by the Commissioner of Customs and Central Excise.2. Classification of products as 'cosmetics' or 'ayurvedic medicines'.3. Finality of prior judicial decisions.4. High Court's interference at the show cause notice stage.Issue-wise Detailed Analysis:1. Jurisdiction and Validity of the Show Cause Notice:The respondent challenged the show cause notice dated 29th April 2005 on the grounds that it sought to re-open and re-litigate issues already concluded by prior decisions of the High Court and the Supreme Court. The High Court quashed the notice, deeming it an abuse of process and without jurisdiction. The appellants argued that the notice was issued based on liberty granted by the Supreme Court in a prior case, allowing for factual adjudication under the correct legal framework.2. Classification of Products:The respondent's products, Vicco Vajradanti and Vicco Turmeric, were initially classified as 'cosmetics' by the Commissioner in 1977, which was later overturned by the Civil Judge, Senior Division, Thane, and upheld by the High Court and the Supreme Court, classifying them as 'ayurvedic medicines'. Despite this, subsequent show cause notices (2nd SCN in 1987 and 3rd SCNs in 1997) attempted to reclassify the products as 'cosmetics' under Chapter 33 of the Central Excise Tariff Act, 1985. The High Court and this Court had consistently ruled in favor of the respondent, affirming the classification as 'ayurvedic medicines'.3. Finality of Prior Judicial Decisions:The High Court and the Supreme Court had previously concluded that the respondent's products were 'ayurvedic medicines'. The Supreme Court's order dated 19th April 1993 affirmed the Bombay High Court's judgment with a modification regarding the refund of amounts paid, subject to Section 11B of the Central Excise and Salt Act, 1944. The appellants' attempts to reclassify the products through subsequent show cause notices were seen as attempts to re-open issues already settled by judicial decisions.4. High Court's Interference at the Show Cause Notice Stage:While the general rule is that courts should not interfere at the show cause notice stage, exceptions exist where notices are issued without jurisdiction or as an abuse of process. The High Court found that the impugned show cause notice was a repetition of earlier notices and not based on any new grounds or different tests. Therefore, it concluded that the notice was an abuse of process and quashed it. The Supreme Court upheld this view, noting that the notice was essentially a repetition of earlier ones and did not present any new factual or legal basis.Conclusion:The appeal was dismissed as it lacked merit. The Supreme Court affirmed that the High Court had rightly quashed the show cause notice, recognizing it as an attempt to re-litigate settled issues. The classification of the respondent's products as 'ayurvedic medicines' was upheld, and the High Court's interference at the show cause notice stage was deemed appropriate given the circumstances.